Needle biopsy after chemotherapy to check for remaining breast cancer
Part of Cancer, Skin clinical trials.
This trial tests a less invasive way to check for remaining breast cancer after chemotherapy, using a needle biopsy instead of surgery. The goal is to confirm that no cancer is left so that some patients might safely skip surgery or have a less extensive operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with invasive breast cancer (any type, including hormone-positive, triple-negative, or HER2-positive).
- You have been recommended to receive chemotherapy before surgery.
- A small marker (clip) was placed in your tumor before starting chemotherapy.
- Tumor is limited to the breast and nearby lymph nodes (stage T1-T3, N0-N1, M0).
- After chemotherapy, imaging shows either no tumor left or only a small remaining spot up to 2 cm.
- You are not taking blood thinners, not pregnant, have no other cancer in the past 5 years, and have no large calcium deposits in the breast.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a special vacuum-assisted biopsy taken just before breast surgery to see how well pre-surgery (neoadjuvant) chemotherapy worked. It may help doctors understand whether patients truly had a complete or near-complete response on scans, which can guide next steps.
This trial checks if a breast biopsy can confirm that chemo has destroyed all cancer cells, so you might avoid surgery altogether. It's for people with aggressive breast cancer types who responded well to chemotherapy.
This study uses ultrasound to monitor a small clip placed in a lymph node affected by breast cancer to see how well it responds to chemotherapy before surgery. It might help predict if the cancer is gone from the lymph nodes without needing extra surgery.
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
This study tests whether some women with breast cancer that has spread to lymph nodes can safely avoid a more extensive lymph node surgery after chemotherapy. If the cancer responds well to chemo, a less invasive procedure may be used.
This trial tests a scanner that checks removed breast tissue during surgery to help surgeons remove all cancer the first time. If it works, fewer women may need a second operation.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.